Influence of sex on intracellular calcium homoeostasis in patients with atrial fibrillation.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
16 03 2022
Historique:
received: 21 10 2020
accepted: 30 03 2021
pubmed: 1 4 2021
medline: 26 4 2022
entrez: 31 3 2021
Statut: ppublish

Résumé

Atrial fibrillation (AF) has been associated with intracellular calcium disturbances in human atrial myocytes, but little is known about the potential influence of sex and we here aimed to address this issue. Alterations in calcium regulatory mechanisms were assessed in human atrial myocytes from patients without AF or with long-standing persistent or permanent AF. Patch-clamp measurements revealed that L-type calcium current (ICa) density was significantly smaller in males with than without AF (-1.15 ± 0.37 vs. -2.06 ± 0.29 pA/pF) but not in females with AF (-1.88 ± 0.40 vs. -2.21 ± 0.0.30 pA/pF). In contrast, transient inward currents (ITi) were more frequent in females with than without AF (1.92 ± 0.36 vs. 1.10 ± 0.19 events/min) but not in males with AF. Moreover, confocal calcium imaging showed that females with AF had more calcium spark sites than those without AF (9.8 ± 1.8 vs. 2.2 ± 1.9 sites/µm2) and sparks were wider (3.0 ± 0.3 vs. 2.2 ± 0.3 µm) and lasted longer (79 ± 6 vs. 55 ± 8 ms), favouring their fusion into calcium waves that triggers ITIs and afterdepolarizations. This was linked to higher ryanodine receptor phosphorylation at s2808 in women with AF, and inhibition of adenosine A2A or beta-adrenergic receptors that modulate s2808 phosphorylation was able to reduce the higher incidence of ITI in women with AF. Perturbations of the calcium homoeostasis in AF is sex-dependent, concurring with increased spontaneous SR calcium release-induced electrical activity in women but not in men, and with diminished ICa density in men only.

Identifiants

pubmed: 33788918
pii: 6206778
doi: 10.1093/cvr/cvab127
pmc: PMC8930070
doi:

Substances chimiques

Ryanodine Receptor Calcium Release Channel 0
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1033-1045

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Can J Physiol Pharmacol. 2018 Oct;96(10):985-990
pubmed: 30001496
Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3584-92
pubmed: 17890429
J Mol Cell Cardiol. 2003 May;35(5):437-43
pubmed: 12738226
Circulation. 1998 Sep 8;98(10):946-52
pubmed: 9737513
Eur Heart J. 2008 May;29(9):1190-7
pubmed: 18397872
Circulation. 2003 May 20;107(19):2459-66
pubmed: 12743001
Circulation. 2004 Sep 14;110(11):1358-63
pubmed: 15313939
Biochem Biophys Res Commun. 2011 Jun 24;410(1):97-101
pubmed: 21640081
Cardiovasc Res. 1999 May;42(2):443-54
pubmed: 10533580
J Am Coll Cardiol. 2010 May 25;55(21):2346-54
pubmed: 20488306
J Physiol. 2015 Mar 15;593(6):1443-58
pubmed: 25384790
J Am Coll Cardiol. 1999 Apr;33(5):1231-7
pubmed: 10193721
Circ Res. 2010 Apr 2;106(6):1134-44
pubmed: 20056922
Cardiovasc Res. 2019 Mar 1;115(3):578-589
pubmed: 30219899
J Physiol. 2011 Jul 1;589(Pt 13):3247-62
pubmed: 21521767
Circulation. 2016 Aug 16;134(7):534-46
pubmed: 27486162
Nat Rev Cardiol. 2016 Jun;13(6):321-32
pubmed: 27053455
Eur Heart J. 2011 Mar;32(6):721-9
pubmed: 21177700
Circulation. 2012 May 1;125(17):2059-70
pubmed: 22456474
Front Physiol. 2018 Oct 09;9:1383
pubmed: 30356673
Eur Heart J. 2015 Mar 14;36(11):686-97
pubmed: 24216388
Circulation. 2005 Apr 26;111(16):2025-32
pubmed: 15851612
Cardiovasc Res. 2015 Apr 1;106(1):76-86
pubmed: 25712961
Circulation. 1996 Dec 1;94(11):2968-74
pubmed: 8941128
Circ Res. 1999 Sep 3;85(5):428-36
pubmed: 10473672
Circulation. 2005 Sep 20;112(12):1701-10
pubmed: 16157773
J Biol Chem. 2007 Sep 21;282(38):28063-73
pubmed: 17656369
Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H1031-H1043
pubmed: 28778911
Cardiovasc Res. 2002 May;54(2):230-46
pubmed: 12062329
Eur Heart J. 2012 Aug;33(16):2098-108
pubmed: 21816854
Circulation. 2014 Jan 14;129(2):145-156
pubmed: 24249718
Circulation. 1995 Oct 1;92(7):1954-68
pubmed: 7671380
Circulation. 2001 May 15;103(19):2365-70
pubmed: 11352885
Cardiol Rev. 2012 Nov-Dec;20(6):297-303
pubmed: 22531673

Auteurs

Adela Herraiz-Martínez (A)

Department of Experimental Pathology, Biomedical Research Institute Barcelona IIBB-CSIC, Rosselló 161, 08036 Barcelona, Spain.
Department of Cardiovascular Disease, IIB Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.

Carmen Tarifa (C)

Department of Experimental Pathology, Biomedical Research Institute Barcelona IIBB-CSIC, Rosselló 161, 08036 Barcelona, Spain.
Department of Cardiovascular Disease, IIB Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.

Verónica Jiménez-Sábado (V)

Department of Cardiovascular Disease, IIB Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.
CIBERCV, Instituto de Salud Carlos III, Pabellón 11, Monforte de Lemos 3-5, 28029 Madrid, Spain.

Anna Llach (A)

Department of Cardiovascular Disease, IIB Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.

Hector Godoy-Marín (H)

Neuropharmacology and Pain Group, Neuroscience Program, IDIBELL, Univ. Barcelona, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
Department of Pathology and Experimental Therapeutics, Neuroscience Institute, Univ. Barcelona, Campus de Mundet Pg. de la Vall d'Hebron, 171 08035 Barcelona, Spain.

Hildegard Colino-Lage (H)

Department of Experimental Pathology, Biomedical Research Institute Barcelona IIBB-CSIC, Rosselló 161, 08036 Barcelona, Spain.
Department of Cardiovascular Disease, IIB Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.

Carme Nolla-Colomer (C)

Department of Automatic Control, Univ. Politècnica de Catalunya, Campus Diagonal Sud, Building H. Av. Diagonal, 647 08028 Barcelona, Spain.

Sergi Casabella-Ramon (S)

Department of Experimental Pathology, Biomedical Research Institute Barcelona IIBB-CSIC, Rosselló 161, 08036 Barcelona, Spain.
Department of Cardiovascular Disease, IIB Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.

Paloma Izquierdo-Castro (P)

Department of Experimental Pathology, Biomedical Research Institute Barcelona IIBB-CSIC, Rosselló 161, 08036 Barcelona, Spain.
Department of Cardiovascular Disease, IIB Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.

Iván Benítez (I)

Biostatistic Unit, Translational Research in Respiratory Medicine, Biomedical Research Institute, IRBLleida, Av. Alcalde Rovira Roure 80, 25198 Lleida, Spain.

Raul Benítez (R)

Department of Automatic Control, Univ. Politècnica de Catalunya, Campus Diagonal Sud, Building H. Av. Diagonal, 647 08028 Barcelona, Spain.

Elena Roselló-Díez (E)

Department of Cardiac Surgery, Hospital de la Santa Creu i Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.
Facultad de Medicina, Univ. Autònoma de Barcelona, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.

Enrique Rodríguez-Font (E)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.

Xavier Viñolas (X)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.

Francisco Ciruela (F)

Neuropharmacology and Pain Group, Neuroscience Program, IDIBELL, Univ. Barcelona, Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
Department of Pathology and Experimental Therapeutics, Neuroscience Institute, Univ. Barcelona, Campus de Mundet Pg. de la Vall d'Hebron, 171 08035 Barcelona, Spain.

Juan Cinca (J)

CIBERCV, Instituto de Salud Carlos III, Pabellón 11, Monforte de Lemos 3-5, 28029 Madrid, Spain.
Facultad de Medicina, Univ. Autònoma de Barcelona, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.
Department of Cardiology, Hospital de la Santa Creu i Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.

Leif Hove-Madsen (L)

Department of Experimental Pathology, Biomedical Research Institute Barcelona IIBB-CSIC, Rosselló 161, 08036 Barcelona, Spain.
Department of Cardiovascular Disease, IIB Sant Pau, St. Antoni Ma. Claret 167, 08025 Barcelona, Spain.
CIBERCV, Instituto de Salud Carlos III, Pabellón 11, Monforte de Lemos 3-5, 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH